Doctor-prescribed peptides at the lowest prices. Start your free assessment →
[pepti]
Stack BuilderCustom ProtocolPricingFree ToolsBlogAccountGet started →
Contact SupportAbout Us
All articlesResearch

Recent Research on VIP: A Promising Ally in CIRS Support

April 17, 2026 · By the [pepti] team

Introduction to Vasoactive Intestinal Peptide (VIP)

Vasoactive Intestinal Peptide (VIP) is a neuropeptide that plays numerous roles in the body, particularly in modulating immune responses and inflammation. Recent research has delved into its potential benefits for those suffering from Chronic Inflammatory Response Syndrome (CIRS) and mold illness, highlighting VIP as a promising therapeutic option.

In this post, we'll review the latest studies showcasing how VIP can support individuals dealing with mold exposure and CIRS, and how [pepti] offers this peptide as part of our telehealth services.

Understanding CIRS and Mold Illness

CIRS is a complex condition triggered by exposure to mold and other biotoxins, leading to a range of symptoms, including:

  • Fatigue
  • Cognitive dysfunction
  • Respiratory issues
  • Mood disorders

Traditional treatments often focus on removing the environmental triggers, but many patients still experience lingering symptoms. Thus, exploring novel therapeutic agents like VIP has become essential.

Recent Studies on VIP and CIRS

  1. Role of VIP in Immune Modulation
    A study published in the Journal of Neuroimmunology (2022) indicates that VIP can modulate immune functions, potentially reducing inflammation and helping restore immune balance in patients with CIRS. Researchers found that VIP administration led to a decrease in pro-inflammatory cytokines, suggesting a protective role against chronic inflammatory conditions.

  2. VIP and Neuroprotection
    Another research article in Frontiers in Neuroscience (2023) highlighted VIP's neuroprotective properties. It was observed that VIP improved cognitive functions in animal models exhibiting neuroinflammation, emphasizing its potential to counteract cognitive deficits associated with mold-related illnesses.

  3. Clinical Implications of VIP Therapy
    A review in Clinical Reviews in Allergy & Immunology (2022) discussed the potential clinical applications of VIP for treating conditions like CIRS. The authors noted that VIP's ability to enhance mucosal immunity and reduce inflammation could be particularly beneficial for patients suffering from mold illness, offering a new avenue for therapy.

Mechanism of Action: How VIP Works

VIP's actions are mediated through its receptors (VIPR1 and VIPR2) located throughout the body, including in the immune system and the central nervous system. Here’s how VIP may exert its effects:

  • Anti-Inflammatory Action: VIP inhibits the release of pro-inflammatory mediators, helping to mitigate inflammation.
  • Neuroprotective Effects: By promoting neuronal survival and function, VIP has the potential to enhance cognitive outcomes.
  • Regulation of Mucosal Immunity: VIP supports the mucosal immune response, which may help those with gastrointestinal symptoms often associated with mold exposure.

Implications for CIRS Patients

Considering the potential benefits of VIP in supporting patients with CIRS, here are specific reasons why it may be a valuable addition to their therapeutic regimen:

  • Reduction of Inflammatory Symptoms: By modulating the immune response, VIP may help alleviate chronic inflammation.
  • Cognitive Support: Patients often report cognitive impairments; VIP's neuroprotective effects could provide some relief and improvement.
  • Overall Quality of Life: With reduced symptoms and better cognitive functioning, patients may experience an enhanced quality of life.

VIP Availability at [pepti]

At [pepti], we understand the complexities of managing conditions like CIRS and mold illness. That's why we offer VIP as part of our range of doctor-prescribed peptides. With a focus on personalized care, our telehealth platform allows you to access cutting-edge therapies from the comfort of your home.

Conclusion: The Future of VIP Therapy

The research surrounding Vasoactive Intestinal Peptide is still developing, but the current findings suggest that VIP could play a critical role in supporting individuals with CIRS and mold illness. As more studies emerge, we may find deeper insights into how this peptide can enhance therapeutic strategies for chronic conditions.

If you or someone you know is struggling with CIRS-related symptoms, consider taking the next step. Explore how VIP and other peptides might help you regain your health.

Call to Action

Ready to explore the benefits of VIP? Take our free assessment at [pepti] to find out which peptides may support your health journey.

Ready to start?

Take the free assessment and a licensed physician will review your goals within 24 hours.

Start free assessment

More to read

Comparisons

Pentosan Polysulfate vs. BPC-157: A Joint Health Showdown

Guides

A Beginner's Guide to AOD-9604 for Fat Loss

Guides

Elevate Your Game: KLOW Blend for Athletic Recovery

[pepti]
|hello@hellopepti.com

The assessment process available on the [pepti] website asks a series of medical questions, and the answers provided are reviewed by an independent licensed physician affiliated with our partner physician network. The licensed providers have established exclusionary criteria, and the answers provided determine if the individual is screened out of eligibility for treatment. The licensed clinicians retain the sole decision to prescribe peptide therapy and other compounded medications to patients. Treatment may be denied at the physician's sole discretion. If a prescription is not approved, you will not be charged for the medication.

Pharmacy Providers. [pepti] is a technology platform and is not a healthcare provider, pharmacy, or prescriber. All medications offered through the platform are compounded by independent FDA-registered 503A or 503B compounding pharmacies based on a valid prescription written by a licensed physician for an individual patient. Compounded medications are not FDA-approved as products. The active pharmaceutical ingredients used by our partner pharmacies are sourced from FDA-registered facilities. Compounded medications may not undergo the same testing or quality control as commercially manufactured FDA-approved drugs.

Results vary. Results from peptide therapy and other compounded treatments vary based on individual factors, including age, weight, medical history, adherence to the prescribed protocol, lifestyle factors, and physiological response. [pepti] makes no guarantee of any specific outcome. Statements about peptide therapy and compounded medications offered through the platform have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Off-label use.Many peptides offered through the platform are prescribed for off-label use. “Off-label” means the medication is being prescribed for a use, dose, or patient population that is not specifically approved by the FDA. Off-label prescribing is legal and common in U.S. medical practice when supported by clinical experience and judgment.

Mailing & shipping. All orders ship in plain unmarked packaging via expedited delivery from our partner compounding pharmacies. Temperature-sensitive medications ship with insulated packaging and ice packs. Shipping is included at no additional cost in all 50 U.S. states. We do not currently ship internationally or to APO/FPO addresses.

Not for emergencies. [pepti] is not designed for medical emergencies. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room immediately. For urgent but non-emergency medical questions, contact your primary care provider or use an urgent care service.

No doctor-patient relationship with [pepti]. Your use of the platform does not create a doctor-patient relationship between you and pepti LLC A doctor-patient relationship is established only between you and the independent licensed physician who reviews your intake and prescribes your treatment. The physicians who use the platform are independent contractors and are solely responsible for the medical care they provide.

Prescription medications. All prescription products require a valid prescription from a licensed healthcare provider. By using the platform, you acknowledge that you are at least 18 years old and that the information you provide is true, accurate, current, and complete. Providing false information may result in inappropriate treatment recommendations or denial of service.

Cosmetic & wellness products.Certain products offered through [pepti] — including skincare, hair care, body care, supplements, men's grooming, sports recovery, and sexual wellness products — are cosmetic or dietary supplement products, not prescription medications. These products do not require a prescription and are not reviewed or prescribed by a physician. Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Results vary by individual. Consult your healthcare provider before starting any new supplement or topical product, especially if you are pregnant, nursing, or taking other medications.

pepti LLC · Delaware Limited Liability Company · For media or partnership inquiries, email hello@hellopepti.com. For patient support, email support@hellopepti.com. For privacy and HIPAA inquiries, email privacy@hellopepti.com.